The Guiliano Law Firm, P.C. is investigating claims on behalf of purchasers of Heartware International (NASDAQ: HTWR) between November 15, 2010 and April 15, 2011.

HeartWare International, Inc., a medical device company, engages in the design, manufacture, and marketing of medical devices for the treatment of advanced heart failure.

On April 15, 2011, HeartWare shares opening price was 18.8% lower than Friday’s closing. The stock opened today at at $68.11.

HeartWare International Shares Plummet

The shares plummeted after company announced that it was required to updated data from its pivotal bridge to heart transplantation (BTT) study, contrary to the Company’s previous announcement in November 2010, that the ADVANCE study achieved its primary endpoint of establishing noninferiority between the investigational device and comparator arm of the study.

Guiliano Law Firm

The practice of Nicholas J. Guiliano, Esq., and The Guiliano Law Firm, P.C., is limited to the representation of investors in claims for fraud in connection with the sale of securities, the sale or recommendation of excessively risky or unsuitable securities, breach of fiduciary duty, and the failure to supervise. We accept representation on a contingent fee basis, meaning there is no cost to unless we make a recovery for you, and there is never any charge for a consultation or an evaluation of your claim. For more information contact us at (877) SEC-ATTY.

Comments are closed.